ALLUVIUM BIOSCIENCES, INC.

Address

2574 BEDFORD RD
ANN ARBOR, MI, 48104-4008

Information

DUNS: 830576703
# of Employees: 2

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. An innovative metabolic engineering strategy for the discovery of novel macrolide antibiotics

    Amount: $224,910.00

    DESCRIPTION provided by applicant The rapid emergence of multi drug resistant pathogenic microorganisms represents a major threat to public health placing an ever increasing demand for the discove ...

    SBIRPhase I2016Department of Health and Human Services
  2. Development of a heterologous bio-production system for the clinically important anti-cancer natural product compound ET-743

    Amount: $194,740.00

    DESCRIPTION provided by applicant Ecteinascidin ET is a tetrahydroisoquinolone natural product that displays potent anti cancer activity Isolated in very low yields from the marine colon ...

    SBIRPhase I2015Department of Health and Human Services
  3. Development of a novel biocatalytic fatty acid decarboxylation technology for production of liquid biofuels

    Amount: $99,999.00

    Throughout the past decade, there has been increasing urgency to develop novel technologies for alternative energy sources. This is being driven by the consequential relationships of increased global ...

    SBIRPhase I2013Department of Agriculture
  4. A genetic engineering strategy for the improved production of the anti-helminthic

    Amount: $170,521.00

    DESCRIPTION (provided by applicant): Helminth infections are responsible for severe health problems worldwide, in both human and animal populations. It is estimated that 2-3 billion people, mainly fro ...

    SBIRPhase I2012Department of Health and Human Services
  5. A novel biosynthetic strategy for the production of a key cryptophycin precursor

    Amount: $114,971.00

    DESCRIPTION (provided by applicant): The cryptophycins are a structurally diverse class of polyketide/non-ribosomal peptide natural products that possess potent anticancer activity. In fact, a cryptop ...

    SBIRPhase I2010Department of Health and Human Services
  6. A chemoenzymatic technology for the efficient synthesis of novel cryptophycins

    Amount: $322,693.00

    DESCRIPTION (provided by applicant): The cryptophycins are a structurally diverse class of polyketide/non-ribosomal peptide natural products that possess potent anticancer activity. However, despite t ...

    STTRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government